Jade Biosciences (JBIO) Change in Account Payables (2020 - 2026)

Jade Biosciences (JBIO) has 7 years of Change in Account Payables data on file, last reported at $2.3 million in Q1 2026.

• Quarterly Change in Account Payables fell 13.04% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12000.0 (down 99.77% YoY) and the FY2025 annual result came in at $361000.0, up 116.62% from the prior year.
• Change in Account Payables advanced to $2.3 million in Q1 2026, from $301000.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $2.7 million in Q1 2025 to a low of -$4.9 million in Q3 2025.
• A 5-year average of $427294.1 and a median of $835000.0 in 2024 frame the typical range for Change in Account Payables.
• Annual changes were most pronounced in 2024 — Change in Account Payables soared 223.56% — and 2025, when it sank 1736.91%.
• Tracing JBIO's Change in Account Payables over 5 years: stood at -$1.7 million in 2022, then soared by 40.31% to -$1.0 million in 2023, then soared by 223.56% to $1.3 million in 2024, then plunged by 76.67% to $301000.0 in 2025, then jumped by 673.42% to $2.3 million in 2026.
• The last three Change in Account Payables figures came in at $2.3 million (Q1 2026), $301000.0 (Q4 2025), and -$4.9 million (Q3 2025), per Business Quant data.